The preventable burden of pneumococcal disease in the developing world.
about
Economic evaluation of pneumococcal conjugate vaccination in The GambiaPneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010Role of conjugative elements in the evolution of the multidrug-resistant pandemic clone Streptococcus pneumoniaeSpain23F ST81Appropriateness of administrative data for vaccine impact evaluation: the case of pneumonia hospitalizations and pneumococcal vaccine in Brazil.Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccineSerotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid.Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trialEnhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid.Serotype replacement in disease after pneumococcal vaccinationSerotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice.A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccinesAssessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and MaPneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introductionStructurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivoFactors Associated with Streptococcal Bacteremia in Diarrheal Children under Five Years of Age and Their Outcome in an Urban Hospital in BangladeshPneumococcal carriage among HIV infected children in Accra, GhanaThe adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal miceThe Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological MethodologiesImproving Capture of Vaccine History: Case Study from an Evaluation of 10-Valent Pneumococcal Conjugate Vaccine Introduction in KenyaSerotype-specific problems associated with pneumococcal conjugate vaccination.Seven-valent pneumococcal conjugate vaccines for developing countries.Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice.10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a reviewUse of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years.Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.Microorganisms Associated With Pneumonia in Children <5 Years of Age in Developing and Emerging Countries: The GABRIEL Pneumonia Multicenter, Prospective, Case-Control Study.Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination.Radical serotype rearrangement of carried pneumococci in the first 3 years after intensive vaccination started in Hungary.Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.Invasive disease and paediatric carriage of Streptococcus pneumoniae in Ghana.Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection.Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.
P2860
Q21261836-86FBFA2B-3F83-45FF-B9FE-5B7B2F98F03CQ28359834-12E22969-964A-478D-A364-C54E252408FAQ30374128-7A94F159-6D1D-4EB7-9137-0363F2B4FD7DQ30807600-29299F5A-0DED-4C14-BAFE-2B59B05EEE57Q33343077-81FA375E-A251-4F29-B800-04DFF6C46FEEQ33627288-59BCE44A-4459-451D-B4F9-C7A3380D6F10Q34058016-55BB558D-2F9B-42F0-B8B5-1F01DA20B104Q34087265-68BAFF75-E373-41F6-89E4-6EAB8593F1E9Q34178363-EC8A21DD-1E7E-41E4-9029-7BEC13C1EBFBQ34516757-EF4AC84F-78C8-4C06-BA5A-19B480219AD9Q34529480-B0AA4C5B-0124-446D-A4CC-F2F5D9080289Q34780775-8E68C9DB-5E14-402C-836E-1301ADAE5829Q34796940-46A372AB-58E9-4F79-B7AD-2A9AB3894AB1Q34867264-CBE84F84-C88C-4ABC-BD50-715F3D474EC5Q35117891-A1D2DB0E-512C-4259-84B6-DD5F90ECA77FQ35199208-50F57037-D549-4AE1-8BB2-C727772E7FC0Q35896017-8978DA98-91B8-4E51-9186-4360EE5176DFQ35980776-0B170453-E27E-4344-9C6E-C45394D361F4Q36005109-51C5C9DB-ED7F-4B05-B297-E3DE210F0B6DQ36274529-4B3C5AD8-AFA8-4912-B010-BEBA50B59226Q36393411-83AB9BEB-1EE9-4A76-BC56-89AD912D9D7EQ36635657-F9C6C2B9-17A5-4021-90F3-DA989157CF90Q36958577-57104CC3-5C65-4E90-89C3-F8990A93019BQ37071137-AF941227-AEF2-4AAB-ABFE-CCE2D2DB135FQ37559638-804BD750-1DF4-4EDA-87BF-0338ED808698Q37607163-909831BF-F18F-4DAB-8015-5FB8B16D1F96Q37622887-9FE1E5FD-23DD-489C-823A-F5014F5B3EDBQ37693513-B34AEABE-8DCF-435F-BCEE-8AAA92EABDBAQ38124392-A99A5EA0-84B8-49F2-8EFA-23637BF7F442Q38966571-1C19B112-20B5-4E76-A3C6-4F20B035B0CDQ40163269-0B43D586-F477-4928-95F9-DEC19E0105E8Q40918160-B99E3EDF-9B0A-410C-87A3-4F0B1090B308Q41758733-B65B692B-9F5B-4A44-B6CC-DFABFCAD722CQ42171376-A8647E93-1E87-42F0-81BE-4EDFB8236E8FQ45817942-6A418BA1-4910-4018-B1F2-1D52B5E134A5Q46120618-4AF6962D-FE94-4A37-B8F5-FFD24263F635Q51744963-A061AFFA-6F8B-4AF5-AD71-49B631A080C0Q54325064-C1703403-6ACB-431F-B40F-D23C2D9DBFB4
P2860
The preventable burden of pneumococcal disease in the developing world.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The preventable burden of pneumococcal disease in the developing world.
@ast
The preventable burden of pneumococcal disease in the developing world.
@en
type
label
The preventable burden of pneumococcal disease in the developing world.
@ast
The preventable burden of pneumococcal disease in the developing world.
@en
prefLabel
The preventable burden of pneumococcal disease in the developing world.
@ast
The preventable burden of pneumococcal disease in the developing world.
@en
P1433
P1476
The preventable burden of pneumococcal disease in the developing world.
@en
P2093
J A G Scott
P304
P356
10.1016/J.VACCINE.2006.09.008
P407
P577
2006-09-18T00:00:00Z